Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

260 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group.
Terpos E, Dimopoulos MA, Sezer O, Roodman D, Abildgaard N, Vescio R, Tosi P, Garcia-Sanz R, Davies F, Chanan-Khan A, Palumbo A, Sonneveld P, Drake MT, Harousseau JL, Anderson KC, Durie BG; International Myeloma Working Group. Terpos E, et al. Among authors: durie bg. Leukemia. 2010 Oct;24(10):1700-12. doi: 10.1038/leu.2010.173. Epub 2010 Sep 2. Leukemia. 2010. PMID: 20811404 Free article. Review.
Carfilzomib, thalidomide, and dexamethasone are safe and effective in relapsed and/or refractory multiple myeloma: final report of the single-arm, multicenter, phase II ALLG MM018/AMN002 study.
Ninkovic S, Harrison SJ, Lee JJ, Murphy N, Lee JH, Estell J, Chen VM, Horvath N, Kim K, Eek R, Augustson B, Bang SM, Huang SY, Rajagopal R, Szabo F, Engeler D, Butcher BE, Mollee P, Durie B, Chng WJ, Quach H. Ninkovic S, et al. Haematologica. 2024 Jul 1;109(7):2229-2238. doi: 10.3324/haematol.2023.284238. Haematologica. 2024. PMID: 38235519 Free PMC article. Clinical Trial.
Population-based screening cohort study reveals no association between monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM), multiple myeloma (MM), and alopecia.
Sharma D, Ungar B, Adalsteinsson JA, Sigurdsson JK, Sharp K, Thorsteinsdóttir S, Rögnvaldsson S, Þórðardóttir ÁR, Viðarsson B, Önundarson PT, Agnarssond BA, Sigurðardóttird M, Þorsteinsdóttir I, Ólafsson Í, Eyþórsson E, Jónsson Á, Ólafsson A, Gíslason GK, Landgren O, Hulcrantz M, Durie BG, Harding S, Love TJ, Kristinsson SY. Sharma D, et al. Among authors: durie bg. Arch Dermatol Res. 2024 Sep 14;316(9):627. doi: 10.1007/s00403-024-03372-8. Arch Dermatol Res. 2024. PMID: 39276205 No abstract available.
Monoclonal gammopathy of undetermined significance with multiple paraproteins: A population-based screening study.
Rögnvaldsson S, Óskarsson JÞ, Thorsteinsdóttir S, Hultcrantz M, Palmason R, Sverrisdottir IS, Eythorsson E, Long TE, Olafsson I, Thorsteinsdottir I, Vidarsson B, Onundarson PT, Agnarsson BA, Sigurdardottir M, Jonsson A, Durie BGM, Harding S, Landgren O, Love TJ, Kristinsson SY. Rögnvaldsson S, et al. Among authors: durie bgm. Hemasphere. 2024 Nov 19;8(11):e70046. doi: 10.1002/hem3.70046. eCollection 2024 Nov. Hemasphere. 2024. PMID: 39564537 Free PMC article.
Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM Registry.
Ailawadhi S, Lee HC, Omel J, Toomey K, Hardin JW, Gasparetto CJ, Jagannath S, Rifkin RM, Durie BGM, Narang M, Terebelo HR, Joshi P, Jou YM, Mouro J, Yu E, Abonour R. Ailawadhi S, et al. Among authors: durie bgm. Blood Cancer J. 2024 Nov 11;14(1):198. doi: 10.1038/s41408-024-01177-6. Blood Cancer J. 2024. PMID: 39528478 Free PMC article.
Association Between Autoimmune Diseases and Monoclonal Gammopathy of Undetermined Significance : An Analysis From a Population-Based Screening Study.
Sverrisdottir I, Thorsteinsdottir S, Rognvaldsson S, Aspelund T, Vidarsson B, Onundarson PT, Agnarsson BA, Sigurdardottir M, Thorsteinsdóttir I, Sveinsdottir SV, Palmason R, Olafsson I, Sigurdsson F, Thordardóttir AR, Eythorsson E, Jonsson A, Palsson R, Indridason OS, Gislason GK, Olafsson A, Sigurdsson J, Steingrímsdóttir H, Einarsson Long T, Hultcrantz M, Durie BGM, Harding S, Landgren O, Kristinsson SY, Love TJ. Sverrisdottir I, et al. Among authors: durie bgm. Ann Intern Med. 2024 Jun;177(6):711-718. doi: 10.7326/M23-2867. Epub 2024 May 21. Ann Intern Med. 2024. PMID: 38768457
Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons With Monoclonal Gammopathy of Undetermined Significance : A Cohort Study Nested in a Clinical Trial.
Eythorsson E, Rognvaldsson S, Thorsteinsdottir S, Einarsson Long T, Reed ER, Sigurdardottir GA, Vidarsson B, Onundarson PT, Agnarsson BA, Sigurdardottir M, Olafsson I, Thorsteinsdottir I, Sveinsdottir SV, Sigurdsson F, Thordardottir AR, Palsson R, Indridason OS, Jonsson A, Gislason GK, Olafsson A, Sigurdsson J, Steingrimsdottir H, Hultcrantz M, Durie BGM, Harding S, Landgren O, Aspelund T, Love TJ, Kristinsson SY. Eythorsson E, et al. Among authors: durie bgm. Ann Intern Med. 2024 Apr;177(4):449-457. doi: 10.7326/M23-2540. Epub 2024 Apr 2. Ann Intern Med. 2024. PMID: 38560901
Prior cancer and risk of monoclonal gammopathy of undetermined significance: a population-based study in Iceland and Sweden.
Rögnvaldsson S, Thorsteinsdóttir S, Syriopoulou E, Sverrisdottir I, Turesson I, Eythorsson E, Oskarsson JT, Long TE, Vidarsson B, Onundarson PT, Agnarsson BA, Sigurdardottir M, Olafsson I, Thorsteinsdottir I, Aspelund T, Gislason GK, Olafsson A, Sigurdsson JK, Hultcrantz M, Durie BGM, Harding S, Bjorkholm M, Landgren O, Love TJ, Kristinsson SY. Rögnvaldsson S, et al. Among authors: durie bgm. Haematologica. 2024 Jul 1;109(7):2250-2255. doi: 10.3324/haematol.2023.284365. Haematologica. 2024. PMID: 38205512 Free PMC article.
260 results